Nogo-B受体在恶性实体肿瘤发病中的抑制和促进作用

doi:10.16098/j.issn.0529-1356.2021.03.025

摘要/Abstract

摘要：

Nogo-B是网状蛋白家族4的重要成员，广泛表达于中枢神经系统及外周组织。研究显示，Nogo-B能与Nogo受体1（NgR1）、Nogo-B特异性受体（NgBR）和配对免疫球蛋白样受体B（PirB）3种不同的受体结合，受体通过RhoA/Rho相关蛋白激酶（ROCK）、磷脂酰肌醇-3激酶/蛋白激酶B（PI3K/Akt）、磷酸腺苷活化激酶α/肝X受α（AMPAα/LXRα）、细胞外信号调节激酶（ERK）、上皮-间质转化（EMT）以及未折叠蛋白反应（UPR）等多个信号通路，在血管生成、增殖和凋亡以及侵袭和迁移等肿瘤发生和发展过程中发挥抑制和促进的双重作用。了解Nogo-B受体参与肿瘤发病的机制将会为治疗药物的开发提供新的思路。我们将对Nogo-B及其受体的基本结构和表达以及Nogo-B受体信号通路在恶性实体肿瘤发生和发展中的抑制和促进作用等方面的最新研究进展做一简要综述。

关键词: Nogo-B, 受体, 肿瘤, 信号通路

Abstract:

Nogo-B is a major family member of the reticulon protein family 4. It is widely expressed in the central nervous system and peripheral tissues. Studies have shown that Nogo-B binds to three different receptors: Nogo receptor-1 (NgR1), Nogo-B specific receptor(NgBR) and paired immunoglobulin like receptor B(PirB). These receptors play a dual role of suppression and promotion in angiogenesis, proliferation and apoptosis, invasion and migration, which are important events in tumor development and progression, through various post-receptor signaling pathways, including RhoA/Rho-associated coiled-coil contaning protein kinase(RhoA/ROCK), phosphatidylinositol 3-kinase/protein kinase B(PI3K/Akt), adenosine 5-monophosphate-activated protein kinase α/liver X receptor α(AMPAα/LXRα), extracellular signal-regulated kinase(ERK), epithelial-mesenchymal transition(EMT), unfolded protein response(UPR) and so on. An in-depth understanding of the mechanisms by which Nogo-B receptors are involved in tumor pathogene is will provide new insights into the development of drugs. Here, we will summarize the up-to-date researches on the basic structure and expression of Nogo-B/Nogo-B receptors and the suppressing/activating effects of post-receptor signaling pathways in the pathogenesis of malignant solid tumors.

Key words: Nogo-B, Receptor, Tumor, Signaling pathway

中图分类号:

R730.2

苏昊任捷秦丽华. Nogo-B受体在恶性实体肿瘤发病中的抑制和促进作用[J]. 解剖学报, 2021, 52(3): 489-494.

SU Hao REN Jie QIN Li-hua. Suppressing and activating effects of Nogo-B receptors in the pathogenesis of malignant solid tumors[J]. Acta Anatomica Sinica, 2021, 52(3): 489-494.

参考文献

［1］ Hu QG, Liu HC, Chen L, et al. Nogo-A in the rat dorsal root ganglion promotes the polymerization of tubulin and inflammatory heat hyperalgesia ［J］. Acta Anatomica Sinica, 2019, 50(5):549-553. (in Chinese)
胡启国，刘怀存, 陈玲，等. 大鼠背根神经节中的Nogo-A蛋白促进微管聚合和炎症热痛觉敏化的发生［J］.解剖学报，2019, 50(5):549-553.
［2］ Pu Y, Ran X. Advances in research of Nogo protein in cardiovascular diseases［J］. Advances in Cardiovascular Diseases, 2018, 39(3):486-489.(In Chinese)
蒲艳, 冉迅. Nogo蛋白在心血管疾病中的研究进展［J］. 心血管病学进展，2018，39(3):486-489.
［3］ Wang M, Han Y, Zhang XP, et al. Nogo,a star protein in reticulon family ［J］. Neurosci Bull, 2006,22(3):183-186.
［4］ Chen MS, Huber AB, van der Haar ME, et al. Nogo-a is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody in-1 ［J］. Nature, 2000,403(6768):434-439.
［5］ Oertle T, van der Haar ME, Bandtlow CE, et al. Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions ［J］. J Neurosci, 2003,23(13):5393-5406.
［6］ Fournier AE, GrandPre T, Strittmatter SM. Identification of a receptor mediating nogo-66 inhibition of axonal regeneration ［J］. Nature, 2001,409(6818):341-346.
［7］ Li M, Song J. The N-and C-termini of the human nogo molecules are intrinsically unstructured: bioinformatics, CD, NMR characterization, and functional implications ［J］. Proteins, 2007,68(1):100-108.
［8］ Huber AB, Weinmann O, Brosamle C, et al. Patterns of nogo mrna and protein expression in the developing and adult rat and after cns lesions ［J］. J Neurosci, 2002,22(9):3553-3567.
［9］ Yang XM, Zhou ChM. Advances in the study of nogo-A protein［J］. Chinese Journal of Neuroanatomy, 2004, 20(3):319-321.(in Chinese)
杨晓梅, 周长满. Nogo-A蛋白的研究进展［J］. 神经解剖学杂志，2004，20(3):319-321.
［10］ Hou PF, Yao Y, Xin HR, et al. The progress in functions and mechanism of Nogo-B in inflammatory diseases［J］. Immunological Journal, 2018,34(3):265-268.(in Chinese)
侯鹏飞, 姚远, 辛浩然, 等. Nogo-B在炎症性疾病中的作用及相关机制研究进展［J］. 免疫学杂志, 2018,34(3):265-268.
［11］ Dodd DA, Niederoest B, Bloechlinger S, et al. Nogo-A,-B, and-C are found on the cell surface and interact together in many different cell types ［J］. J Biol Chem, 2005,280(13):12494-12502.
［12］ Acevedo L, Yu J, Erdjument-Bromage H, et al. A new role for nogo as a regulator of vascular remodeling ［J］. Nat Med, 2004,10(4):382-388.
［13］ Bullard TA, Protack TL, Aguilar F, et al. Identification of nogo as a novel indicator of heart failure ［J］. Physiol Genomics, 2008,32(2):182-189.
［14］ Sarkey JP. Nogo-A knockdown inhibits hypoxia/reoxygenation-induced activation of mitochondrial-dependent apoptosis in cardiomyocytes ［J］. Biophys J, 2011,100(3):41-41.
［15］ Zhang Y, Huang Y, Cantalupo A, et al. Endothelial nogo-b regulates sphingolipid biosynthesis to promote pathological cardiac hypertrophy during chronic pressure overload ［J］. JCI Insight, 2016,1(5): e85484.
［16］ Wen L, Jia S, Xu C, et al. Nogo-C regulates post myocardial infarction fibrosis through the interaction with ER Ca2+ leakage channel Sec61α in mouse hearts ［J］. Cell Death Dis, 2018,9(6):612.
［17］ Ding Y, Gao BB, Zhou L, et al. Clinical implications of plasma nogo-a levels in patients with coronary heart disease ［J］. Arch Med Sci, 2017,13(4):771-777.
［18］ Gao BB, Xu YZ, Leng JH, et al. Clinical implications of increased nogo-b levels in patients with acute coronary syndromes and stable angina pectoris ［J］. Int Heart J, 2015,56(3):341-344.
［19］ Jia S, Qiao X, Ye J, et al. Nogo-C regulates cardiomyocyte apoptosis during mouse myocardial infarction ［J］. Cell Death Dis, 2016,7(10):e2432.
［20］ Ran X, Zhao JX, Chen YCh, et al. The different Nogo expression in heart tissues of rats with different degrees of right heart failure［J］. Sichuan Medical Journal, 2017,38(1)1-3.(in Chinese)
冉迅, 赵健洵, 陈玉成, et al. 不同程度右心衰竭大鼠心脏组织nogo的表达差异［J］. 四川医学, 2017,38(1):1-3.
［21］ Niederost B, Oertle T, Fritsche J, et al. Nogo-a and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of rhoa and rac1 ［J］. J Neurosci, 2002,22(23):10368-10376.
［22］ Wang ZhL, Zhang Y, Wang J. Role of Nogo-A and Nogo-A receptors in Alzheimer’s disease［J］. Acta Annatomica Sinica, 2018, 49(4):549-555.(in Chinese)
王兆伦, 张艳, 王君. Nogo-A及其受体在阿尔茨海默病中的作用［J］. 解剖学报, 2018,49(4):549-555.
［23］ Rousseau S, Peggie M, Campbell DG, et al. Nogo-B is a new physiological substrate for mapkap-k2 ［J］. Biochem J, 2005,391(Pt2)：433-440.
［24］ Yu J, Fernandez-Hernando C, Suarez Y, et al. Reticulon 4B (Nogo-B) is necessary for macrophage infiltration and tissue repair ［J］. Proc Natl Acad Sci USA, 2009,106(41):17511-17516.
［25］ Zhu Y, Tong Q, Ye J, et al. Nogo-B facilitates LPS-mediated immune responses by up-regulation of TLR4-signaling in macrophage RAW264.7 ［J］. Cell Physiol Biochem, 2017,41(1):274-285.
［26］ Drozdz K, Grzegorek Ⅰ, Chmielewska M, et al. Nogo-B expression, in arterial intima, is impeded in the early stages of atherosclerosis in humans ［J］. APMIS, 2014,122(9):742-749.
［27］ Rauch BH. Sphingosine 1-phosphate as a link between blood coagulation and inflammation ［J］. Cell Physiol Biochem, 2014,34(1):185-196.
［28］ Cantalupo A, Zhang Y, Kothiya M, et al. Nogo-B regulates endothelial sphingolipid homeostasis to control vascular function and blood pressure ［J］. Nat Med, 2015,21(9):1028-1037.
［29］ Li J, Wu WC, Xin YG, et al. Inhibition of Nogo-B promotes cardiac hypertrophy via endoplasmic reticulum stress ［J］. Biomed Pharmacother, 2018,104：193-203.
［30］ Ramires FJ, Sun Y, Weber KT. Myocardial fibrosis associated with aldosterone or angiotensin Ⅱ administration: attenuation by calcium channel blockade ［J］. J Mol Cell Cardiol, 1998,30(3):475-483.

[1]	洪晓敏李三强崔钦奕郑润月杨孟利罗仁利李前辉 . 酒精性肝纤维化核因子κB信号通路与性别的差异 [J]. 解剖学报, 2024, 55(1): 55-61.
[2]	魏茜茜李超红赵晨露唐家萍刘玉珍. 大鼠颈上神经节中Ⅰ组代谢型谷氨酸受体表达及慢性间歇性低氧对其的影响 [J]. 解剖学报, 2024, 55(1): 3-9.
[3]	袁蕾杨智伟杨惠刘政海何洁万炜. 三七总皂苷抑制小鼠星形胶质细胞活化缓解完全弗氏佐剂所致炎性痛 [J]. 解剖学报, 2024, 55(1): 25-31.
[4]	马婷婷陈建红刘爱翠李海宁. 抑制lncRNA TUG1下调核苷酸结合寡聚结构域样受体蛋白1炎症小体在延缓阿尔茨海默病进展的作用 [J]. 解剖学报, 2024, 55(1): 32-42.
[5]	陈子璇司丽娜舒薇菡张欣魏晨阳程露阳杨松鹤乔跃兵. 褪黑素调控下丘脑PI3K/Akt/mTOR信号延缓雌性小鼠青春期启动的机制 [J]. 解剖学报, 2023, 54(6): 644-651.
[6]	姚素华鄢骏谢芳林春华黄争春 . 奥氮平介导环磷酸腺苷反应元件结合蛋白/脑源性神经营养因子/酪氨酸蛋白激酶受体B通路对精神分裂模型大鼠的神经修复作用 [J]. 解剖学报, 2023, 54(6): 660-667.
[7]	徐颖刘斌郑兴何宗钊. 补体C3a受体在盲肠结扎穿孔致脓毒症大鼠认知障碍中的作用及机制 [J]. 解剖学报, 2023, 54(6): 668-675.
[8]	吴俊波杨杰肖锋李金亮 . 微小RNA-138调控Wnt通路对体外人脑胶质瘤细胞生物学行为的影响 [J]. 解剖学报, 2023, 54(6): 682-688.
[9]	李霞朱世杰唐中生罗亚非范瑞娟谢高宇寇云芳陆莹 . 电针智三针调节酪氨酸激酶受体的配体通路改善血管性痴呆的作用机制[J]. 解剖学报, 2023, 54(6): 689-694.
[10]	张亚清吉维忠王玲. N-甲基-D-天冬氨酸受体/MAPK/环磷腺苷效应元件结合蛋白通路在前扣带皮层介导痛相关情绪[J]. 解剖学报, 2023, 54(5): 512-520.
[11]	燕洋洋郭凯孙志宏 . 嘌呤能离子通道型受体7介导的帕金森大鼠认知功能障碍[J]. 解剖学报, 2023, 54(5): 531-537.
[12]	何可可李远迪文廷浩朱婕高杰胡蓉韩锋苏敏. 红细胞膜相关蛋白通过IL-6/STAT3/ROR-γt 信号通路抑制小鼠实验性自身免疫性脑脊髓炎中Th17细胞分化[J]. 解剖学报, 2023, 54(5): 538-545.
[13]	季睿婕李雯金国华张新化. 回旋引导受体1在丙戊酸钠诱导神经干细胞分化过程中的表达和作用[J]. 解剖学报, 2023, 54(3): 255-260.
[14]	张沂洲李莎米世雄左洪春张倩倩李晗琳雷梓晗张东泽崔慧先. 雌二醇经雌激素受体调控分拣蛋白相关受体A对小鼠海马神经元树突棘密度和突触蛋白表达的影响[J]. 解剖学报, 2023, 54(3): 261-268.
[15]	李婷钰王兴航迟晓晨李昆芳包翠芬. 人参皂苷Rg1通过过氧化物酶体增殖物激活受体γ调控脂多糖诱导的炎症反应中BV2小胶质细胞的极化[J]. 解剖学报, 2023, 54(3): 269-275.